Impact of health-related quality of life on repeat protocol biopsy compliance on active surveillance for favorable prostate cancer: results from a prospective cohort in the PRIAS-JAPAN study

•Lower MCS at AS enrollment leads in lower compliance with first repeat protocol biopsy.•How health-related quality of life of repeat protocol biopsy non-compliance was lower than that of compliance at any point.•How health-related quality of life during AS influence patients’ decision-making further protocol examination.